Scaling Cell Therapy Manufacturing: From Tech Transfer to High-Volume Readiness

Commercial cell therapy raises the bar on throughput, reproducibility, and cost, even for processes designed with scale in mind. This session lays out a practical roadmap for that step-change: facility design, process standardization, and digital execution chosen together, not bolted on. It covers a tech transfer model built for scale and closes with the Partner-in-Plant model, where embedded teams and integrated training standardize best practices, reduce variability, and accelerate ramp to scale.